Serum Levels of Bone Turnover Markers Including Calculation of -scores: Data from a Dutch Healthy Reference Cohort

Overview

Journal Bone Rep

Date 2023 Dec 4

PMID 38047270

Authors

Mark Siderius

Suzanne Arends

Anneke Muller Kobold

Lucie Wagenmakers

Karin Koerts

Anneke Spoorenberg

Eveline van der Veer

Affiliations

Soon will be listed here.

Abstract

Introduction: Bone turnover markers (BTM) are biochemical compounds reflecting different stages of bone metabolism. Their levels change with age and differ between males and females. This makes clinical interpretation and comparison more difficult. Therefore, our aim was to establish BTM reference values which can be used to calculate -scores for use in daily clinical practice.

Methods: Serum markers of collagen resorption, bone formation/regulation, collagen formation and bone mineralization (sCTX, OC, PINP and BALP, respectively) were measured in non-fasting volunteers without bone-related abnormalities. Raw data was plotted and gender-specific age cohorts were established with their respective means and standard deviations (SD). -scores can be calculated using these reference values to correct for the influence of age and gender on BTM.

Results: In total, 856 individuals were included of which 486 (57 %) were female. Individuals were aged between 7 and 70 years. Highest serum levels of BTM were found in childhood and puberty. Peak levels are higher in boys than girls and prevail at later ages. In adults, BTM levels decrease before reaching stable nadir levels. In adults, 10-year reference cohorts with means and SD were provided to calculate -scores.

Conclusion: With our data, -scores of sCTX, OC, PINP and BALP can be calculated using reference categories (for age and gender) of Caucasian healthy volunteers. Clinicians can use BTM -scores to determine whether there are changes in bone turnover physiology beyond those expected during aging. BTM Z-scores facilitate harmonization of data interpretation in daily clinical practice and research.

Citing Articles

Association between Bone Turnover Markers and Fracture Healing in Long Bone Non-Union: A Systematic Review.

Perut F, Roncuzzi L, Gomez-Barrena E, Baldini N J Clin Med. 2024; 13(8).

PMID: 38673606 PMC: 11051214. DOI: 10.3390/jcm13082333.

References

Shuhart C, Yeap S, Anderson P, Jankowski L, Lewiecki E, Morse L . Executive Summary of the 2019 ISCD Position Development Conference on Monitoring Treatment, DXA Cross-calibration and Least Significant Change, Spinal Cord Injury, Peri-prosthetic and Orthopedic Bone Health, Transgender Medicine, and Pediatrics. J Clin Densitom. 2019; 22(4):453-471. DOI: 10.1016/j.jocd.2019.07.001. View

Eekman D, Bultink I, Heijboer A, Dijkmans B, Lems W . Bone turnover is adequately suppressed in osteoporotic patients treated with bisphosphonates in daily practice. BMC Musculoskelet Disord. 2011; 12:167. PMC: 3146915. DOI: 10.1186/1471-2474-12-167. View

Eastell R . Role of oestrogen in the regulation of bone turnover at the menarche. J Endocrinol. 2005; 185(2):223-34. DOI: 10.1677/joe.1.06059. View

Christensen G, Halgreen J, Milenkovski M, Kose A, Quardon N, Jorgensen N . Bone turnover markers are differentially affected by pre-analytical handling. Osteoporos Int. 2019; 30(5):1137-1141. DOI: 10.1007/s00198-019-04837-7. View

Siderius M, Spoorenberg A, Kroese F, van der Veer E, Arends S . After an initial balance favoring collagen formation and mineralization, bone turnover markers return to pre-treatment levels during long-term TNF-α inhibition in patients with ankylosing spondylitis. PLoS One. 2023; 18(3):e0283579. PMC: 10038252. DOI: 10.1371/journal.pone.0283579. View

Greenblatt M, Tsai J, Wein M . Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease. Clin Chem. 2016; 63(2):464-474. PMC: 5549920. DOI: 10.1373/clinchem.2016.259085. View

Lombardi G, Lanteri P, Colombini A, Banfi G . Blood biochemical markers of bone turnover: pre-analytical and technical aspects of sample collection and handling. Clin Chem Lab Med. 2012; 50(5):771-89. DOI: 10.1515/cclm-2011-0614. View

Marrone J, Maddalozzo G, Branscum A, Hardin K, Cialdella-Kam L, Philbrick K . Moderate alcohol intake lowers biochemical markers of bone turnover in postmenopausal women. Menopause. 2012; 19(9):974-9. PMC: 3597753. DOI: 10.1097/GME.0b013e31824ac071. View

Jorde R, Stunes A, Kubiak J, Grimnes G, Thorsby P, Syversen U . Smoking and other determinants of bone turnover. PLoS One. 2019; 14(11):e0225539. PMC: 6876776. DOI: 10.1371/journal.pone.0225539. View

10.

Herrmann M, Seibel M . The effects of hormonal contraceptives on bone turnover markers and bone health. Clin Endocrinol (Oxf). 2009; 72(5):571-83. DOI: 10.1111/j.1365-2265.2009.03688.x. View

11.

Chubb S, Byrnes E, Manning L, Beilby J, Ebeling P, Vasikaran S . Reference intervals for bone turnover markers and their association with incident hip fractures in older men: the Health in Men study. J Clin Endocrinol Metab. 2014; 100(1):90-9. DOI: 10.1210/jc.2014-2646. View

12.

Avbersek-Luznik I, Stopar T, Marc J . Activity or mass concentration of bone-specific alkaline phosphatase as a marker of bone formation. Clin Chem Lab Med. 2007; 45(8):1014-8. DOI: 10.1515/CCLM.2007.186. View

13.

Hannemann A, Friedrich N, Spielhagen C, Rettig R, Ittermann T, Nauck M . Reference intervals for serum osteocalcin concentrations in adult men and women from the study of health in Pomerania. BMC Endocr Disord. 2013; 13:11. PMC: 3606466. DOI: 10.1186/1472-6823-13-11. View

14.

Bhattoa H . Laboratory aspects and clinical utility of bone turnover markers. EJIFCC. 2018; 29(2):117-128. PMC: 6053812. View

15.

van der Veer E, Arends S, van der Hoek S, Versluijs J, de Monchy J, Oude Elberink J . Predictors of new fragility fractures after diagnosis of indolent systemic mastocytosis. J Allergy Clin Immunol. 2014; 134(6):1413-1421. DOI: 10.1016/j.jaci.2014.05.003. View

16.

Ivaska K, Gerdhem P, Akesson K, Garnero P, Obrant K . Effect of fracture on bone turnover markers: a longitudinal study comparing marker levels before and after injury in 113 elderly women. J Bone Miner Res. 2007; 22(8):1155-64. DOI: 10.1359/jbmr.070505. View

17.

Bayer M . Reference values of osteocalcin and procollagen type I N-propeptide plasma levels in a healthy Central European population aged 0-18 years. Osteoporos Int. 2013; 25(2):729-36. DOI: 10.1007/s00198-013-2485-4. View

18.

Jenkins N, Black M, Paul E, Pasco J, Kotowicz M, Schneider H . Age-related reference intervals for bone turnover markers from an Australian reference population. Bone. 2013; 55(2):271-6. DOI: 10.1016/j.bone.2013.04.003. View

19.

Szulc P, Naylor K, Hoyle N, Eastell R, Leary E . Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability. Osteoporos Int. 2017; 28(9):2541-2556. DOI: 10.1007/s00198-017-4082-4. View

20.

Vasikaran S, Eastell R, Bruyere O, Foldes A, Garnero P, Griesmacher A . Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int. 2010; 22(2):391-420. DOI: 10.1007/s00198-010-1501-1. View